Hutchison China MediTech Limited ('Chi-Med')
(AIM: HCM)
Date of Annual General Meeting
London: Friday, 20 March 2009: Chi-Med announces that the Annual General Meeting ('AGM') will be held at Citigate Dewe Rogerson, 3 London Wall Buildings, London, EC2M 5SY on Friday, 8 May 2009 at 11:00 am. Notice of the AGM will be posted to shareholders in due course.
Ends
Enquiries
Chi-Med Christian Hogg, CEO |
Telephone: +852 2121 8200 |
|
|
Citigate Dewe Rogerson Anthony Carlisle David Dible |
Telephone: +44 (0) 20 7638 9571 +44 (0) 7973 611 888 +44 (0) 7967 566 919 |
About Chi-Med
Chi-Med is the holding company of a pharmaceutical and healthcare group based primarily in China and was admitted to trading on the Alternative Investment Market of the London Stock Exchange in May 2006. It is focused on researching, developing, manufacturing, and selling pharmaceuticals, health supplements and other consumer health and personal care products derived from Traditional Chinese Medicine and botanical ingredients.
Chi-Med is majority owned by Hutchison Whampoa Limited, an international company listed on the Main Board of The Stock Exchange of Hong Kong Limited.